SECUADO®, the first and only
FDA-approved transdermal system
for adults with schizophrenia: IT’S ON™
Why transdermal?
When your patients with schizophrenia are ready for a change of treatment, the transdermal patch offers you the opportunity to change the conversation with a different treatment option. The SECUADO® patch is an option for your patients who:
• Are looking for or need a different atypical antipsychotic treatment • Want an alternative to swallowing pills or receiving injections • Dislike food or drink restrictions when taking medicine • Might be candidates for a once-daily treatment they can wear
Transdermal delivery is different
SECUADO® releases medication gradually, for consistent and sustained delivery over 24 hours.1,3 The transdermal route of administration avoids first-pass hepatic metabolism4-6 and has the potential to reduce GI tolerability concerns.4,5,7 Absorption is not impacted by the timing of food or drink.4,7
You are now leaving the SECUADO® (asenapine) transdermal system website and moving to an external website independently operated and not managed by Noven